Vanda's eczema drug fails mid-stage study
March 04, 2015 at 16:57 PM EST
March 4 (Reuters) - Vanda Pharmaceuticals Inc said its experimental atopic dermatitis drug failed a mid-stage study to treat chronic itching, sending its shares down 8.7 percent in after-hours trading.